Sign in Subscribe
Genetic research

New Insights into Lymphoma: Antigen Selection in Disease Ontogeny

Strategic Insights

— 1 min read

Research published by the Institute of Applied Biosciences reveals a crucial link between antigen selection and the development of splenic marginal zone lymphoma (SMZL). The study found that almost one-third of all SMZL cases express B-cell receptor immunoglobulin (BcR IG) encoded by the IGHV1-2*04 gene, suggesting that antigen selection plays a significant role in shaping the disease's ontogeny. The research highlights the importance of high-throughput immunogenetic investigation in understanding the subclonal architecture of SMZL and the impact of antigen selection on disease progression.

Key Takeaways:

  • The study found that almost one-third of all SMZL cases express the IGHV1-2*04 gene, implicating antigen selection in disease ontogeny.
  • High-throughput immunogenetic investigation revealed significant differences in somatic hypermutation (SHM) and intraclonal diversification profiles between cases expressing the IGHV1-2*04 gene and those expressing other IGHV genes.
  • The IGHV1-2*04 gene cases displayed targeted SHM and intraclonal diversification, reflecting ongoing antigen selection.
  • The study suggests that SMZL cases expressing the IGHV1-2*04 gene may represent a distinct molecular variant of SMZL.
  • The research highlights the importance of antigen selection in shaping the subclonal architecture of SMZL.
  • The study's findings have implications for understanding disease progression and developing targeted therapies.

Statistics:

  • Almost one-third of all SMZL cases express the IGHV1-2*04 gene (1/3).
  • High-throughput immunogenetic investigation revealed significant differences in SHM and intraclonal diversification profiles (2).
  • The IGHV1-2*04 cases displayed targeted SHM with recurrent replacement SHMs.
  • Intraclonal diversification was significantly more pronounced in IGHV1-2*04 cases (2).

Sources:

  • Antigen selection reflected in the subclonal architecture of the B-cell receptor immunoglobulin gene repertoire in splenic marginal zone lymphoma. HemaSphere, 2025, 9(5): n/a-n/a. (HemaSphere - http://www.hemaspherejournal.com)
  • Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece
  • Hellenic Foundation For Research And Innovation
  • European Commission
  • Institute of Applied Biosciences
  • Hematology Week (June 16, 2025, p 901)

Read more